Opportunistic fungal infections in the Asia-Pacific region

Medical Mycology

Volumn 50, Issue 1, 2012, Pages 18-25

  Slavin, Monica A ^a   Chakrabarti, Arunaloke ^b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Asia; Aspergillus; Candida; opportunistic mycoses; Pacific

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE;

ASIA; ASPERGILLOSIS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDIASIS; CRYPTOCOCCOSIS; DEBRIDEMENT; DISEASE TRANSMISSION; ENDOPHTHALMITIS; FUSARIOSIS; INFECTION RISK; KERATITIS; LUNG INFECTION; MUCORMYCOSIS; MYCOSIS; OPPORTUNISTIC INFECTION; PACIFIC ISLANDS; PETRIELLIDIUM BOYDII; PSEUDALLESCHERIASIS; PUBLIC HEALTH PROBLEM; PYTHIOSIS; REVIEW; RHIZOPUS ORYZAE; SCEDOSPORIUM APIOSPERMUM; SINUSITIS; TRICHOSPORON ASAHII; TRICHOSPORONOSIS;

ASIA; HUMANS; INCIDENCE; MYCOSES; OPPORTUNISTIC INFECTIONS; PACIFIC ISLANDS; PREVALENCE;

EID: 83755188653     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2011.602989     Document Type: Review

References (113)

1. Central Intelligence Agency. World factbook: Country comparison, population. Central Intelligence Agency Web site. 2010. Available at: https://www.cia.gov/library/publications/the-world-factbook/ index.html. Accessed May 17, 2011.
2. Hutin YJ, Hauri AM, Armstrong GL. Use of injections in healthcare settings worldwide, 2000: literature review and regional estimates. BMJ 2003; 327: 1075.
3. Shears P. Poverty and infection in the developing world: healthcarerelated infections and infection control in the tropics. J Hosp Infect 2007; 67: 217-224. (Pubitemid 350028519)
4. Pittet D, Allegranzi B, Storr J, .et al. Infection control as a major World Health Organization priority for developing countries. J Hosp Infect 2008; 68: 285-292.
5. Chakrabarti A, Chatterjee SS, Das A, Shivaprakash MR. Invasive aspergillosis in developing countries. Med Mycol 2011; 49 (Suppl 1): S35 - 47.
6. Thursky KA, Playford EG, Seymour JF, et al. Recommendations for the treatment of established fungal infections. Intern Med J 2008; 38: 496-520. (Pubitemid 351904422)
7. Pappas PG, Kauffman CA, Andes D, .et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. infect. Dis. 2009; 48: 503-535.
8. Garey KW, Rege M, Pai MP, .et al. Time to initiation of fl uconazole therapy impacts mortality in patients with candidemia: A multiinstitutional study. Clin. infect. Dis. 2006; 43: 25-31. (Pubitemid 43939072)
9. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: A potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005; 49: 3640-3645. (Pubitemid 41233011)
10. Pai MP, Turpin RS, Garey KW. Association of fl uconazole area under the concentration-time curve/MIC and dose/MIC ratios with mortality in nonneutropenic patients with candidemia. Antimicrob Agents Chemother 2007; 51: 35-39. (Pubitemid 46047684)
11. Patterson TF, Boucher HW, Herbrecht R. .et al. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome. Clin. infect. Dis. 2005; 41: 1448-1452. (Pubitemid 41579987)
12. Patterson TF. Treatment of invasive aspergillosis: polyenes, echinocandins, or azoles? Med Mycol 2006; 44: 357-362.
13. Cooley L, Spelman D, Thursky K, Slavin M. Infection with S cedosporium apiospermum and S. prolifi cans Australia. Emerg Infect Dis 2007; 13: 1170-1177. (Pubitemid 47359160)
14. Gunaratne PS, Wijeyaratne CN, Chandrasiri P, .et al. An outbreak of Aspergillus meningitis following spinal anaesthesia for caesarean section in Sri Lanka: A post-tsunami effect? Ceylon Med J 2006; 51: 137-142.
15. Kim HJ, Park YJ, Kim WU, Park SH, Cho CS. Invasive fungal infections in patients with systemic lupus erythematosus: Experience from affi liated hospitals of Catholic University of Korea. Lupus 2009; 18: 661-666.
16. Yamazaki T, Kume H, Murase S, Yamashita E, Arisawa M. Epidemiology of visceral mycoses: Analysis of data in annual of the pathological autopsy cases in Japan. J Clin Microbiol 1999; 37: 1732-1738. (Pubitemid 29235215)
17. Slavin M, Fastenau J, Sukarom I, .et al. Burden of hospitalization of patients with Candida and Aspergillus infections in Australia. Int J Infect Dis 2004; 8: 111-120. (Pubitemid 38166077)
18. Meis JF, Chakrabarti A. Changing epidemiology of an emerging infection: zygomycosis. Clin Microbiol Infect 2009; 15 (Suppl 5): 10-14.
19. United Nations Statistics Division. Composition of macro geographical (continental) regions, geographical sub-regions, and selected economic and other groupings. United Nations Statistics Division Web site. 2010. Available at: http://unstats.un.org/unsd/methods/ m49/m49regin.htm. Accessed May 26, 2010.
20. Slavin MA; the Australian Mycology Interest Group. The epidemiology of candidaemia and mould infections in Australia. J Antimicrob Chemother 2002; 49: 3-6. (Pubitemid 34162650)
21. Kiertiburanakul S, Thibbadee C, Santanirand P. Invasive aspergillosis in a tertiary-care hospital in Thailand. J Med Assoc Thai 2007; 90: 895-902. (Pubitemid 46790352)
22. Kume H, Yamazaki T, Abe M, et al. Increase in aspergillosis and severe mycotic infection in patients with leukemia and MDS: Comparison of the data from the Annual of the Pathological Autopsy Cases in Japan in 1989, 1993 and 1997. Pathol Int 2003; 53: 744-750. (Pubitemid 37491529)
23. Park SY, Kim SH, Choi SH, et al. Clinical and radiological features of invasive pulmonary aspergillosis in transplant recipients and neutropenic patients. Transplant Infect Dis 2010; 12: 309-315.
24. Chakrabarti A, Chatterjee SS, Shivaprakash MR. Overview of opportunistic fungal infections in India. Nippon Ishinkin Gakkai Zasshi 2008; 49: 165-172.
25. Pongbhaesaj P, Dejthevaporn C, Tunlayadechanont S, .et al. Aspergillosis of the central nervous system: A catastrophic opportunistic infection. Southeast Asian J Trop Med Public Health 2004; 35: 119-125. (Pubitemid 38860067)
26. Chakrabarti A, Shivaprakash MR, Singh R, .et al. Fungal endophthalmitis: fourteen years experience from a center in India. Retina 2008; 28: 1400-1407.
27. Chang CC, Cheng AC, Devitt B, et al. Successful control of an outbreak of invasive aspergillosis in a regional haematology unit during hospital construction works. J Hosp Infect 2008; 69: 33-38.
28. Cooper EE, O Reilly MA, Guest DI, Dharmage SC. Infl uence of building construction work on Aspergillus infection in a hospital setting. Infect Control Hosp Epidemiol 2003; 24: 472-476. (Pubitemid 36919264)
29. Khor BS, Lee MH, Leu HS, Liu JW. Rhinocerebral mucormycosis in Taiwan. J Microbiol Immunol Infect 2003; 36: 266-269.
30. Peel T, Daffy J, Thursky K, Stanley P, Buising K. Posaconazole as fi rst line treatment for disseminated zygomycosis. Mycoses 2008; 51: 542-545.
31. Kok J, Gilroy N, Halliday C, et al. Early use of posaconazole in the successful treatment of rhino-orbital mucormycosis caused by Rhizopus oryzae. J Infect 2007; 55: E33-e36. (Pubitemid 47244921)
32. Wong TY. A nationwide survey of deaths from oral and maxillofacial infections: the Taiwanese experience. J Oral Maxillofac Surg 1999; 57: 1297-1299.
33. Jung JH, Choi HJ, Yoo J, Kang SJ, Lee KY. Emphysematous gastritis associated with invasive gastric mucormycosis: A case report. J Korean Med Sci 2007; 22: 923-927.
34. Tio JH, Djojopranoto M, Tyoei EN. Subcutaneous phycomycosis in children in East-Java. Paediatr Indones 1965; 5: 519-526.
35. Kobayashi M, Hiruma M, Matsushita A, .et al. Cutaneous zygomycosis: A case report and review of Japanese reports. Mycoses 2001; 44: 311-315.
36. Chakrabarti A, Das A, Mandal J, .et al. The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol 2006; 44: 335-342. (Pubitemid 43922068)
37. Diwakar A, Dewan RK, Chowdhary A, .et al. Zygomycosis - a case report and overview of the disease in India. Mycoses 2007; 50: 247-254. (Pubitemid 46920279)
38. Higa M. Clinical epidemiology of fungal infection in diabetes. Nippon Rinsho 2008; 66: 2239-2244 [in Japanese].
39. Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China.nEngl J Med 2010; 362: 1090-1101.
40. Neville SE, Boye KS, Montgomery WS, .et al. Diabetes in Japan: A review of disease burden and approaches to treatment. Diab Metabol Res Rev 2009; 25: 705-716.
41. Rao CR, Kamath VG, Shetty A, Kamath A. A study on the prevalence of type 2 diabetes in coastal Karnataka. Int J Diab Dev Ctries 2010; 30: 80-85.
42. Bellamy R, Sangeetha S, Paton NI. AIDS-defi ning illnesses among patients with HIV in Singapore, 1985 to 2001: results from the Singapore HIV Observational Cohort Study (SHOCS). BMC Infect Dis 2004; 4: 47.
43. Bellamy R, Sangeetha S, Paton NI. Causes of death among patients with HIV in Singapore from 1985 to 2001: results from the Singapore HIV Observational Cohort Study (SHOCS). HIV Med 2004; 5: 289-295. (Pubitemid 39077122)
44. Oh MD, Park SW, Kim HB, et al. Spectrum of opportunistic infections and malignancies in patients with human immunodefi ciency virus infection in South Korea. Clin. infect. Dis. 1999; 29: 1524-1528. (Pubitemid 30022752)
45. Nissapatorn V, Lee C, Fatt QK, Abdullah KA. AIDS-related opportunistic infections in Hospital Kuala Lumpur. Japan J Infect Dis 2003; 56: 187-192. (Pubitemid 38208628)
46. Jain D, Kumar Y, Vasishta RK, .et al. Zygomycotic necrotizing fasciitis in immunocompetent patients: A series of 18 cases. Mod Pathol 2006; 19: 1221-1226. (Pubitemid 44268192)
47. Cooter RD, Lim IS, Ellis DH, Leitch IO. Burn wound zygomycosis caused by Apophysomyces elegans. J Clin Microbiol 1990; 28: 2151-2153. (Pubitemid 20261014)
48. Andresen D, Donaldson A, Choo L, .et al. Multifocal cutaneous mucormycosis complicating polymicrobial wound infections in a tsunami survivor from Sri Lanka. Lancet 2005; 365: 876-878. (Pubitemid 40332166)
49. Snell BJ, Tavakoli K. Necrotizing fasciitis caused by A pophysomyces elegans complicating soft-tissue and pelvic injuries in a tsunami survivor from Thailand. Plast Reconstr Surg 2007; 119: 448-449. (Pubitemid 46360321)
50. Chakrabarti A, Ghosh A, Prasad GS, .et al. Apophysomyces elegans: An emerging zygomycete in India. J Clin Microbiol 2003; 41: 783-788. (Pubitemid 36184197)
51. Chakrabarti A, Marak RS, Shivaprakash MR, .et al. Cavitary pulmonary zygomycosis caused by Rhizopus homothallicus. J Clin Microbiol 2010; 48: 1965-1969.
52. Supabandhu J, Fisher MC, Mendoza L, Vanittanakom N. Isolation and identifi cation of the human pathogen Pythium insidiosum from environmental samples collected in Thai agricultural areas. Med Mycol 2008; 46: 41-52. (Pubitemid 351298240)
53. Kammarnjesadakul P, Palaga T, Sritunyalucksana K, .et al. Phylogenetic analysis of Pythium insidiosum Thai strains using cytochrome oxidase II (COX II) DNA coding sequences and internal transcribed spacer regions (ITS). Med Mycol 2011; 49: 289-295.
54. Badenoch PR, Mills RA, Chang JH, .et al. Pythium insidiosum keratitis in an Australian child. Clin Exper Ophthalmol 2009; 37: 806-809.
55. Murdoch D, Parr D. P ythium insidiosum keratitis. A ustnZ J Ophthalmol 1997; 25: 177-179. (Pubitemid 27322160)
56. Laohapensang K, Rutherford RB, Supabandhu J, Vanittanakom N. Vascular pythiosis in a thalassemic patient. Vascular 2009; 17: 234-238.
57. Jindayok T, Piromsontikorn S, Srimuang S, Khupulsup K, Krajaejun T. Hemagglutination test for rapid serodiagnosis of human pythiosis. Clin Vaccine Immunol 2009; 16: 1047-1051.
58. Heath CH, Slavin MA, Sorrell TC, .et al. Population-based surveillance for scedosporiosis in Australia: Epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection. Clin Microbiol Infect 2009; 15: 689-693.
59. Hsiue HC, Ruan SY, Kuo YL, Huang YT, Hsueh PR. Invasive infections caused by non- Aspergillus moulds identifi ed by sequencing analysis at a tertiary care hospital in Taiwan, 2000 - 2008. Clin Microbiol Infect 2010; 16: 1204-1206.
60. Leechawengwongs M, Milindankura S, Liengudom A, et al. Multiple Scedosporium apiospermum brain abscesses after near-drowning successfully treated with surgery and long-term voriconazole: A case report. Mycoses 2007; 50: 512-516. (Pubitemid 47609823)
61. Satirapoj B, Ruangkanchanasetr P, Treewatchareekorn S, .et al. Pseudallescheria boydii brain abscess in a renal transplant recipient: fi rst case report in Southeast Asia. Transplant Proc 2008; 40: 2425-2427.
62. Gopinath M, Cherian A, Baheti NN, .et al. An elusive diagnosis: S cedosporium apiospermum infection after near-drowning. Ann Indian Acad Neurol 2010; 13: 213-215.
63. Sireesha P, Manoj Kumar CH, Setty CR. Thyroid abscess due to Scedosporium apiospermum. Indian J Med Microbiol 2010; 28: 409-411.
64. Makino K, Fukushima S, Maruo K, .et al. Cutaneous hyalohyphomycosis by Scedosporium apiospermum in an immunocompromised patient. Mycoses 2009; 54: 259-261.
65. Garzoni C, Emonet S, Legout L, et al. Atypical infections in tsunami survivors. Emerg Infect Dis 2005; 11: 1591-1593. (Pubitemid 41384347)
66. Delhaes L, Harun A, Chen SC, et al. Molecular typing of Australian Scedosporium isolates showing genetic variability and numerous S. aurantiacum. Emerg Infect Dis 2008; 14: 282-290. (Pubitemid 351213679)
67. Hu JW, Shu XR, Ren J, .et al. F usarium solani infection in a patient after allogeneic hemotopoietic stem cell transplantation: Case report and literature review. Zhonghua Jie He He Hu Xi Za Zhi 2010; 33: 730-733 [in Chinese].
68. Rekha A, Kindo AJ, Ravi A. F usarium solani in the post-transplant patient: An unusual fungus. Int J Low Extrem Wounds 2008; 7: 38-40. (Pubitemid 351364436)
69. Chen QX, Li CX, Huang WM, Shi JQ, Li SF. Cutaneous hyalohyphomycosis caused by Fusarium subglutinans. Eur J Dermatol 2010; 20: 526-527.
70. Kindo AJ, Rana NS, Rekha A, Kalyani J. Fungal infections in the soft tissue: A study from a tertiary care center. Indian J Med Microbiol 2010; 28: 164-166.
71. Wu CY, Chen GS, Lan CC. Onychomycosis caused by F usarium solani in a woman with diabetes. Clin Exp Dermatol 2009; 34: E772 - 774.
72. Chen S, Slavin M, Nguyen Q, .et al. Active surveillance for candidemia, Australia. Emerg Infect Dis 2006; 12: 1508-1516.
73. Xess I, Jain N, Hasan F, Mandal P, Banerjee U. Epidemiology of candidemia in a tertiary care centre of north India: 5-year study. Infection 2007; 35: 256-259. (Pubitemid 47222273)
74. Hope W, Morton A, Eisen DP. Increase in prevalence of nosocomial non- Candida albicans candidaemia and the association of Candida kruseiwith fl uconazole use. J Hosp Infect 2002; 50: 56-65. (Pubitemid 37554682)
75. Chai YA, Wang Y, Khoo AL, et al. Predominance of C andida tropicalis bloodstream infections in a Singapore teaching hospital. Med Mycol 2007; 45: 435-439. (Pubitemid 47190129)
76. Tan TY, Tan AL, Tee NW, Ng LS, Chee CW. The increased role of non- albicans species in candidaemia: results from a 3-year surveillance study. Mycoses 2010; 53: 515-521.
77. Tan TY, Tan AL, Tee NW, Ng LS. A retrospective analysis of antifungal susceptibilities of Candida bloodstream isolates from Singapore hospitals. Ann Acad Med Singapore 2008; 37: 835-840.
78. Ruan SY, Hsueh PR. Invasive candidiasis: An overview from Taiwan. J Formos Med Assoc 2009; 108: 443-451.
79. Foongladda S, Sakulmaiwatana P, Petlum P, Vanprapar N. C andida species, genotypes and antifungal susceptibility of Candida isolates from blood samples of patients at the largest tertiary care hospital in Thailand during 1999 - 2002. J Med Assoc Thai 2004; 87: 92-99. (Pubitemid 38314044)
80. Anunnatsiri S, Chetchotisakd P, Mootsikapun P. Fungemia in non- HIV-infected patients: A fi ve-year review. Int J Infect Dis 2009; 13: 90-96.
81. Jung SI, Shin JH, Song JH, et al. Multicenter surveillance of species distribution and antifungal susceptibilities of Candida bloodstream isolates in South Korea. Med Mycol 2010; 48: 669-674.
82. Kim MN, Shin JH, Sung H, .et al. Candida haemulonii and closely related species at 5 university hospitals in Korea: identifi cation, antifungal susceptibility, and clinical features. Clin. infect. Dis. 2009; 48: E57 - 61.
83. Chakrabarti A, Singh K, Narang A, .et al. Outbreak of P ichia anomala infection in the pediatric service of a tertiary-care center in Northern India. J Clin Microbiol 2001; 39: 1702-1706. (Pubitemid 32417007)
84. Chakrabarti A, Chatterjee SS, Rao KL, .et al. Recent experience with fungaemia: Change in species distribution and azole resistance. Scand J Infect Dis 2009; 41: 275-284.
85. Ruan SY, Chien JY, Hsueh PR. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan. Clin. infect. Dis. 2009; 49: E11 - 17.
86. Suzuki K, Nakase K, Kyo T, et al. Fatal Trichosporon fungemia in patients with hematologic malignancies. Eur J Haematol 2010; 84: 441-447.
87. Chellan G, Shivaprakash S, Karimassery RS, .et al. Spectrum and prevalence of fungi infecting deep tissues of lower-limb wounds in patients with type 2 diabetes. J Clin Microbiol 2010; 48: 2097-2102.
88. Hosoki K, Iwamoto S, Kumamoto T, Azuma E, Komada Y. Early detection of breakthrough trichosporonosis by serum PCR in a cord blood transplant recipient being prophylactically treated with voriconazole. J Pediatr Hematol Oncol 2008; 30: 917-919.
89. Ellis DH, Pfeiffer TJ. Ecology, life cycle, and infectious propagule of Cryptococcus neoformans. Lancet 1990; 336: 923-925. (Pubitemid 20351174)
90. Chayakulkeeree M, Perfect JR. Cryptococcosis.infect Dis Clin North Am 2006; 20: 507-544. (Pubitemid 44375117)
91. Pfeiffer TJ, Ellis DH. Environmental isolation of Cryptococcus neoformans var gattii from Eucalyptus tereticornis. J Med Vet Mycol 1992; 30: 407-408.
92. Springer DJ, Chaturvedi V. Projecting global occurrence of C ryptococcus gattii. Emerg Infect Dis 2010; 16: 14-20.
93. Randhawa HS, Kowshik T, Chowdhary A, .et al. The expanding host tree species spectrum of Cryptococcus gattii and Cryptococcus neoformans and their isolations from surrounding soil in India. Med Mycol 2008; 46: 823-833.
94. Chen S, Sorrell T, Nimmo G, .et al. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin. infect. Dis. 2000; 31: 499-508. (Pubitemid 32289583)
95. Laurenson IF, Lalloo DG, Naraqi S, .et al. Cryptococcus neoformans in Papua New Guinea: A common pathogen but an elusive source. J Med Vet Mycol 1997; 35: 437-440. (Pubitemid 28037538)
96. Seaton RA, Wembri JP, Armstrong P, .et al. Symptomatic human immunodefi ciency virus (HIV) infection in Papua New Guinea. AustnZ J Med 1996; 26: 783-788. (Pubitemid 27072783)
97. Chen J, Varma A, Diaz MR, .et al. Cryptococcus neoformans strains and infection in apparently immunocompetent patients, China. Emerg Infect Dis 2008; 14: 755-762. (Pubitemid 351838639)
98. Tay ST, Rohani MY, Hoo TS, Hamimah H. Epidemiology of cryptococcosis in Malaysia. Mycoses 2010; 53: 509-514.
99. Inverarity D, Bradshaw Q, Wright P, Grant A. The spectrum of HIVrelated disease in rural Central Thailand. Southeast Asian J Trop Med Public Health 2002; 33: 822-831.
100. Wright P, Inverarity D. Human immunodefi ciency virus (HIV) related cryptococcal meningitis in rural central Thailand - treatment diffi culties and prevention strategies. Southeast Asian J Trop Med Public Health 2007; 38: 58-61.
101. Lian YL, Heng BS, Nissapatorn V, Lee C. AIDS-defi ning illnesses: A comparison between before and after commencement of highly active antiretroviral therapy (HAART). Curr HIV Res 2007; 5: 484-489.
102. Chakraborty N, Mukherjee A, Santra S, .et al. Current trends of opportunistic infections among HIV-seropositive patients from Eastern India. Japan J Infect Dis 2008; 61: 49-53. (Pubitemid 351338530)
103. Louie JK, Chi NH, Thao le TT, .et al. Opportunistic infections in hospitalized HIV-infected adults in Ho Chi Minh City, Vietnam: A cross-sectional study. Int J STD AIDS 2004; 15: 758-761. (Pubitemid 39540704)
104. Dore GJ, Li Y, McDonald A, Kaldor JM. Spectrum of AIDS-defi ning illnesses in Australia, 1992 to 1998: infl uence of country/region of birth. J Acquir Immune Defi c Syndr 2001; 26: 283-290.
105. Satpute MG, Telang NV, Litake GM, Niphadkar KB, Joshi SG. Prevalence of cryptococcal meningitis at a tertiary care centre in Western India (1996- 2005). J Med Microbiol 2006; 55: 1301-1302. (Pubitemid 44373170)
106. Capoor MR, Mandal P, Deb M, Aggarwal P, Banerjee U. Current scenario of cryptococcosis and antifungal susceptibility pattern in India: A cause for reappraisal. Mycoses 2008; 51: 258-265. (Pubitemid 351502577)
107. Lui G, Lee N, Ip M, et al. Cryptococcosis in apparently immunocompetent patients. QJM 2006; 99: 143-151.
108. Feng X, Yao Z, Ren D, Liao W, Wu J. Genotype and mating type analysis of Cryptococcus neoformans and Cryptococcus gattii isolates from China that mainly originated from non-HIV-infected patients. FEMS Yeast Res 2008; 8: 930-938.
109. Perfect JR, Dismukes WE, Dromer F, .et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin. infect. Dis. 2010; 50: 291-322.
110. Gomez-Lopez A, Zaragoza O, dos Anjos Martins M, .et al.in vitro susceptibility of Cryptococcus gattii clinical isolates. Clin Microbiol Infect 2008; 14: 727-730. (Pubitemid 351837036)
111. de Bedout C, Ordonez N, Gomez BL, .et al. In vitro antifungal susceptibility of clinical isolates of Cryptococcus neoformans var neoformans and C. neoformans var gattii. Rev Iberoam Micol 1999; 16: 36-39. (Pubitemid 29166856)
112. Varma A, Kwon-Chung KJ. Heteroresistance of C ryptococcus gattii to fl uconazole. Antimicrob Agents Chemother 2010; 54: 2303-2311.
113. Chakrabarti A, Chatterjee SS, Das A, .et al. Invasive zygomycosis in India: Experience in a tertiary care hospital. Postgrad Med J 2009; 85: 573-581.